New CRISPR Tools More Precise, but Targeting Mishaps a Worry – Medscape
DailyTech |
New CRISPR Tools More Precise, but Targeting Mishaps a Worry
Medscape The inner workings of CRISPR 2.0, including the new Cpf1 “scissors” that can cut DNA in a variety of patterns, were described here at the European Society of Gene and Cell Therapy 2016 Annual Congress by Feng Zhang, PhD, from the Broad Institute and … Researchers use CRISPR to Accelerate Search for HIV CureDailyTech New gene-editing technology successfully cures a genetic blood disorder in miceScience Daily In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery …Nature |
Capitol Weekly |
Stem cell: A look at Lou Gehrig’s Disease
Capitol Weekly You might say it is a case of “self-control” involving the test of a stem cell therapy for an infamous and terrible disease. Not self-control in the usual sense, but in the sense of controls during a clinical trial for a treatment prior to its release … |
|
How stem cell technology could revolutionize our food, medicine in our lifetime
Genetic Literacy Project The potential of stem cell therapy, is that damaged organs will be able to be repaired by pin pointing very rare and potent tissue specific stem cells. … 2. Meat-Free Meat. [M]illions are currently being invested in developing stem cell culture which … Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report | Now Available at Researchmoz.usMedgadget (blog) |
|
Feng Zhang Receives 2016 New York Stem Cell Foundation – Robertson Stem Cell Prize
Business Wire (press release) NEW YORK–(BUSINESS WIRE)–The New York Stem Cell Foundation (NYSCF) announced today that Feng Zhang, PhD, is the 2016 recipient of the NYSCF – Robertson Stem Cell Prize for his pioneering advances to edit human and plant genomes using … |
Cornell Chronicle |
$2M gift to drive Weill Cornell advances in immunotherapy
Cornell Chronicle To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis ’76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy, the institution announced today. |